TROGARZO
Total Payments
$1.9M
Transactions
6,836
Doctors
2,073
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $203,674 | 129 | 40 |
| 2023 | $459,414 | 278 | 146 |
| 2022 | $493,901 | 207 | 100 |
| 2021 | $242,181 | 2,318 | 1,045 |
| 2020 | $78,558 | 415 | 262 |
| 2019 | $280,361 | 1,884 | 805 |
| 2018 | $152,866 | 1,605 | 745 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $911,050 | 175 | 47.7% |
| Honoraria | $551,883 | 317 | 28.9% |
| Food and Beverage | $172,331 | 5,873 | 9.0% |
| Consulting Fee | $124,147 | 146 | 6.5% |
| Travel and Lodging | $116,540 | 276 | 6.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,393 | 29 | 1.8% |
| Education | $610.53 | 20 | 0.0% |
Payments by Type
General
$999,906
6,661 transactions
Research
$911,050
175 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) | Theratechnologies Inc. | $469,339 | 2 |
| A Phase 3 Study of the Safety of Trogarzo Administered as an Undiluted IV Push over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo Experienced Patients and Healthy HIV-uninfected Volunteers | Theratechnologies Inc. | $439,459 | 1 |
| Trogarzo TM ibalizumab-uiyk for multidrug resistant HIV-2 | Theratechnologies Inc. | $1,135 | 1 |
Top Doctors Receiving Payments for TROGARZO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Monika Mishra | — | Bridgeport, CT | $685,583 | 153 |
| Gary Richmond | — | Fort Lauderdale, FL | $216,888 | 22 |
| , MD | Infectious Disease | Dallas, TX | $91,389 | 89 |
| , M.D | Internal Medicine | Bronx, NY | $68,633 | 67 |
| , MD | Infectious Disease | Newark, NJ | $68,277 | 68 |
| , FNP | Family | Houston, TX | $67,654 | 75 |
| , DO | Family Medicine | Columbus, OH | $66,857 | 70 |
| , M.D | Internal Medicine | Oakland, CA | $33,976 | 41 |
| , MD | Infectious Disease | Fairfax, VA | $31,528 | 49 |
| , MD | Internal Medicine | Fort Lauderdale, FL | $24,659 | 38 |
| , MD | Family Medicine | Tampa, FL | $21,874 | 39 |
| , MD | Infectious Disease | Southampton, NY | $17,976 | 6 |
| , MD | Infectious Disease | San Juan, PR | $17,854 | 27 |
| Princy Kumar | Infectious Disease | Washington, DC | $17,368 | 26 |
| , MD | Internal Medicine | New Haven, CT | $13,162 | 14 |
| , MD | Internal Medicine | West Hollywood, CA | $12,742 | 7 |
| , MD | Infectious Disease | Las Vegas, NV | $12,306 | 17 |
| , MD | Pediatrics | Charleston, SC | $11,813 | 18 |
| , MD | Infectious Disease | Valhalla, NY | $9,588 | 10 |
| , M.D | Internal Medicine | Washington, DC | $9,130 | 14 |
| , FNP-C | Family | Saint Pauls, NC | $8,365 | 9 |
| , MD | Infectious Disease | Chicago, IL | $7,726 | 12 |
| , MD | Infectious Disease | Altamonte Springs, FL | $7,527 | 12 |
| , M.D | Infectious Disease | Baltimore, MD | $7,179 | 6 |
| , MD | Infectious Disease | Altamonte Springs, FL | $7,064 | 27 |
Ad
Manufacturing Companies
- Theratechnologies Inc. $1.9M
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 2,073
- Transactions 6,836
About TROGARZO
TROGARZO is a drug associated with $1.9M in payments to 2,073 healthcare providers, recorded across 6,836 transactions in the CMS Open Payments database. The primary manufacturer is Theratechnologies Inc..
Payment data is available from 2018 to 2024. In 2024, $203,674 was paid across 129 transactions to 40 doctors.
The most common payment nature for TROGARZO is "Unspecified" ($911,050, 47.7% of total).
TROGARZO is associated with 3 research studies, including "A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US)" ($469,339).